Advanced Technologies & Treatments for Diabetes

⭐Thank you to everyone who submitted research & is advancing diabetes care across Asia. With nearly twice as many abstracts as last edition, ATTD-ASIA 2026 promises our most exciting scientific program yet! 📍Kyoto, Japan 📅 9-11 December 🔗 bit.ly/43UA26A #ATTDASIA26

🎙️ #ATTDDiabetesTalks: Insulin in Practice Episode 8️⃣: "Personalised Approaches for Complex Populations" 🎧 Listen on Spotify: bit.ly/4wZ3JB0 🎧 Listen on Apple Podcasts: apple.co/4vLgLRf This series is supported by #Sanofi. #ATTDEducation #ATTDonUNLOK #UNLOK

⏰ Last chance to register! Tomorrow, join the next #ATTDJournalClub for a live discussion on emerging evidence for inhaled Technosphere insulin in youth living with #T1D. 📅 23 July | 16:00 CEST 👉 Register now: bit.ly/3QXZ2rv Supported by #MannKindCorporation.

🔬Did you know? Paris is home to Europe's largest science museum. Paris provides a fitting setting for bringing together the global diabetes community. Planning your trip to #ATTD2027? Learn more about the host city: 🔗attd2027.kenes.com/visit-paris/ #DiabetesTechnology #Paris

Ready to join us in Kyoto? Whether you're advancing patient care, conducting pioneering research, driving innovation, or exploring the next big breakthrough, ATTD-ASIA is where ideas come together. 📅9-11 December 🔗attdasia.kenes.com/register/ #Diabetes

🙋 Learn from two leading experts in #PediatricDiabetes and explore what the newest evidence could mean for improving postmeal glucose control. 📅 23 July, 2026 | 🕓 16:00 CEST 👉 SECURE YOUR SPOT: bit.ly/4aANKAe This event is supported by #MannKindCorporation.

Innovation deserves to be recognised! The #ATTDASIA26 Clinical Innovation Award celebrates initiatives that make a real difference in the clinical management of type 2 #diabetes. 📅Application deadline: 1 September 🔗Learn more & apply: attdasia.kenes.com/attd-asia-clin…

👉With just 6 days left until the abstract submission deadline, now is the time to showcase your research and join the scientific program at ATTD-ASIA 2026. 📅Submit by 15 July 2026 🔗attdasia.kenes.com/abstract-submi… #ATTDASIA26 #DiabetesTechnology #DiabetesCare

📢We're excited to introduce the ATTD Global Platform - the new digital home for the #ATTD community. Whether you're looking for upcoming events, educational opportunities or the latest news, you'll find it all in one digital hub. 🌐attd.kenes.com #Diabetes

📝Your research could open new conversations, connect you with experts in the field & help advance diabetes care. Submit your abstract for #ATTD2027 and present your work. 📅Deadline: 9 September 🔗attd2027.kenes.com/abstract-submi… #DiabetesResearch #DiabetesTechnology

Join the next #ATTDJournalClub as Dr. Laya Ekhlaspour presents new research on inhaled Technosphere insulin in youth living with #T1D, followed by a Q&A moderated by Dr. Michael Haller. 📅23 July | 16:00 CEST 👉SIGN UP: bit.ly/4aANKAe Supported by MannKind Corporation.

🎙️ #ATTDDiabetesTalks: Insulin in Practice Episode 7️⃣: "Overcoming Barriers to Insulin Adherence" 🎧 Listen on Spotify: bit.ly/4gf93ej 🎧 Listen on Apple Podcasts: apple.co/4vLFIx5 This series is supported by #Sanofi. #ATTDEducation #ATTDonUNLOK #UNLOKEducation

📢Good news! We've extended the abstract submission deadline for #ATTDASIA26 to 15 July 2026. Share your latest findings and contribute to the conversations! 🔗Submit your abstract: attdasia.kenes.com/abstract-submi… #DiabetesTechnology #DiabetesCare

📢New international guidance is available for the use of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists in people with Type 1 Diabetes. Endorsed by #ATTD and several leading diabetes organizations 📖Read the guidance: bit.ly/4gc2kBO #Type1Diabetes #GLP1

Are you presenting, attending, or planning to submit an abstract for #ATTD2027? Download our Promotional Toolkit and access social media covers and other materials to help spread the word. 📥attd2027.kenes.com/promotional-to… #DiabetesTechnology #DiabetesResearch

🤔 Could improving insulin safety also improve patient adherence? If #InsulinTherapy is part of your clinical practice, you won't want to miss this discussion. 👉 Tomorrow at 16:00 CEST: bit.ly/4v1m2F7 Supported by an independent medical educational grant from @sanofi.

Thinking about attending #ATTDASIA26? Now is the perfect time to secure your place at ATTD-ASIA 2026 and take advantage of the early registration rates. 📍Kyoto, Japan 📅9-11 December 2026 🔗Register now: attdasia.kenes.com/register/ #DiabetesTechnology #DiabetesCare

🎙️ #ATTDDiabetesTalks: Insulin in Practice Episode 6️⃣: "Preventing & Managing Hypoglycemia" 🎧 Listen on Spotify: bit.ly/44ory8Q 🎧 Listen on Apple Podcasts: apple.co/4vt5BS6 This series is supported by #Sanofi. #ATTDEducation #ATTDonUNLOK #UNLOKEducation

🤩 Two leading voices in #DiabetesTechnology and #DiabetesCare will headline the upcoming #ATTDWebinar on #InsulinTherapy challenges. 📆 Wednesday, June 24 at 16:00 CEST 👉 REGISTER NOW: bit.ly/4v1m2F7 Supported by an independent medical educational grant from @sanofi.

#ATTDASIA26 には、50か国以上から臨床医、研究者、業界リーダーが集結します。 アジア太平洋地域の糖尿病医療を牽引する人々とつながり、貴社の存在感を高める機会を創出しましょう。 🔗 貴社に最適なパートナーシップについてご相談ください： bit.ly/4ubCBO9 #MedicalConference